Merck KGaA
XETRA:MRK
Merck KGaA
XETRA:MRK
Price:
165.65 EUR
4.64%
Market Closed
Updated:
May 15, 2024
Merck KGaA
Interest Income Expense
|
Merck KGaA
Interest Income Expense Peer Comparison
Comparables:
ATAI
BAYN
93M1
DMP
PSG
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Merck KGaA
XETRA:MRK
|
Interest Income Expense
-€42m
|
CAGR 3-Years
51%
|
CAGR 5-Years
31%
|
CAGR 10-Years
14%
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Interest Income Expense
-$1.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Interest Income Expense
-€852m
|
CAGR 3-Years
3%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-2%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Interest Income Expense
€30.4m
|
CAGR 3-Years
37%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Interest Income Expense
-€75m
|
CAGR 3-Years
-84%
|
CAGR 5-Years
-87%
|
CAGR 10-Years
N/A
|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Interest Income Expense
-€1.9m
|
CAGR 3-Years
-129%
|
CAGR 5-Years
-148%
|
CAGR 10-Years
N/A
|
See Also
What is Merck KGaA's Interest Income Expense?
Interest Income Expense
-42m
EUR
-42m
EUR
Based on the financial report for Dec 31, 2023, Merck KGaA's Interest Income Expense amounts to -42m EUR.
What is Merck KGaA's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
14%
14%
Over the last year, the Interest Income Expense growth was 86%. The average annual Interest Income Expense growth rates for Merck KGaA have been 51% over the past three years , 31% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
